Specialization & Approach
Thompson's specialized knowledge encompasses advanced pharmacological profiling, cognitive behavioral therapy (CBT), and clinical trials design. She has developed and implemented sophisticated in vitro and in vivo models to examine the bioavailability and efficacy of kratom-caffeine combinations, contributing significantly to the understanding of these complex interactions. Her work emphasizes evidence-based practices, utilizing modern analytical techniques to analyze compounds and their effects on various physiological markers.
Thompson's research-based content is developed through a meticulous process that includes extensive literature reviews, experimental design, data analysis, and interpretation. Her approach ensures that each study is meticulously planned and executed, contributing to the advancement of knowledge in this specialized field.
Core Expertise & Skills
Career Milestones
- Conducted a major study comparing the pharmacokinetics of kratom alone versus kratom-caffeine blends in human subjects.
- Designed and implemented clinical trials examining the therapeutic potential of kratom-caffeine combinations for managing chronic pain and fatigue syndromes.
- Developed novel analytical methods to quantify specific alkaloids and their metabolites in complex matrices, enhancing the accuracy of compound identification.
- Contributed to the development of standardized protocols for preclinical and clinical research on kratom derivatives.
Academic Qualifications & Certifications
- Ph.D. in Pharmacognosy, University of California, Berkeley
- M.S. in Clinical Psychology, Stanford University
- Board-Certified in Addiction Medicine (BCAM)
- Fellow of the American College of Pharmacognosy (FACP)
Recognition & Trust
- Her work has been published in high-impact journals including *Journal of Ethnopharmacology* and *Addiction Science & Clinical Practice*.
- Thompson's research has received notable recognition from industry peers and academic institutions.
- She serves on several scientific advisory boards for leading pharmaceutical companies specializing in alternative medicine.
